Azoptic Eye Drops
PDF Leaflet Revision Date: 12 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of elevated intraocular pressure in ocular hypertension or open-angle glaucoma.
Dosage (summary)
One drop in the affected eye(s) twice daily; may increase to three times daily if needed.
Special Populations
- Elderly
- Moderate renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- Oral carbonic anhydrase inhibitors
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity to components
- Severe renal impairment
- Hyperchloraemic acidosis
Common side effects
- Taste perversion
- Temporary blurred vision
- Ocular discomfort
Counselling Points
- Shake well before use
- Remove contact lenses during instillation
- Wait 15 mins before reinserting contact lenses
Serious warnings
- Systemic absorption may cause sulphonamide-related reactions
- Not studied in hepatic impairment
Important Disclaimer
The Azoptic Eye Drops professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
